医療用マリファナ市場：現状分析・予測 (2022年～2028年)

世界の医療用マリファナの市場規模は、2022年から2028年にかけて約21％のCAGRで成長すると予測されています。

同市場の成長は主に、アルツハイマー病、癌、統合失調症などの疾患治療分野での用途が拡大していることに起因しています。用途別で見ると、慢性疼痛の部門が2020年に市場の大半のシェアを示しています。これは主に、疼痛、癌、関節炎、発作の治療の普及が進んでいることに起因しています。また、タイプ別では、オイルおよびチンキ剤の部門が予測期間中に最も高いCAGRを記録する見通しです。

当レポートでは、世界の医療用マリファナの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、法規制環境、需給動向、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法・前提因子

第3章 市場概要

第4章 エグゼクティブサマリー

第5章 COVID-19：医療用マリファナ市場への影響

第6章 医療用マリファナ市場：収益の推移・予測

第7章 市場洞察：用途別

• 慢性疼痛
• 関節炎
• 片頭痛
• 癌
• その他

第8章 市場洞察：タイプ別

• フラワー
• オイル・チンキ剤
• 食用
• その他

第9章 市場洞察：流通チャネル別

• 診療所
• オンラインチャンネル
• その他

第10章 市場洞察：地域別

• 北米
• 欧州
• アジア太平洋
• その他の地域

第11章 医療用マリファナ市場：市場力学

• 市場促進要因
• 市場課題
• 影響分析

第12章 医療用マリファナ市場：市場機会

第13章 医療用マリファナ市場：市場動向

第14章 政策と規制の枠組み

第15章 需要サイド・供給サイドの分析

• 需要サイド分析
• 供給サイド分析

第16章 バリューチェーン分析

第17章 競合シナリオ

第18章 企業プロファイル

• Canopy Growth Corporation
• CANNABIS SATIVA, INC
• GW Pharmaceuticals plc.
• Emerald Health Therapeutics Inc.
• Tilray.
• Aphria Inc
• Aurora Cannabis
• CARA THERAPEUTICS, INC
• Medical Marijuana, Inc
• Pfizer Inc.

第19章 免責事項

The global medical marijuana market is experiencing significant growth due to the increased number of patients suffering from chronic diseases like Epilepsy, Crohn's disease, and Alzheimer's disease and awareness regarding this has also fueled the growth of the medical marijuana market. For instance, Aurora Cannabis, in August 2019, successfully acquired Hempco Food and Fiber Inc., to gain access to cost-effective hemp, to extract cannabidiol (CBD). Similarly, Aphria acquired CC Pharma, which provides numerous pharmaceutical products, such as cannabis, in Germany and other European countries, in January 2019. Cannabidiol (CBD) is a medical benefit associated with the plant are anticipated to boost product demand. Thus, it works by helping to restore the balance to have several medicinal benefits. For instance, epidiolex is a CBD oil extract that is currently undergoing clinical trials for epilepsy. Furthermore, epilepsy is one of the most common neurological diseases globally. Therefore, the market for medical marijuana is expected to witness a significant CAGR of ~21% during the forecast period.

Global medical marijuana market is expected to register a CAGR of around ~21% over the period of 2022-2028. This is mainly due to its increasing application in the therapeutic field for the treatment of such disorders as Alzheimer's disease, cancer, and schizophrenia. It is derived from the Cannabis sativa plant, which can be used for the treatment of chronic diseases and pain management. Medical marijuana has stringent government regulations coupled with the growing focus of major stakeholders in the healthcare industry to adopt to make medical marijuana products more sustainable with fewer side effects and cost-effective. Major healthcare companies are investing heavily in their products due to rising social awareness regarding chronic pain disorder cases, and other associated disorders, such as mania, anxiety, cancer, and treatment of seizures. For instance, in 2018, the Centers for Disease Control and Prevention (CDC) reported that an estimated 50 million Americans, or just over 20 percent, have some form of chronic pain. This rise in the demand for cannabis in medical is contributing to market growth. Furthermore, various factors such as growing research and development activities are also expected to drive the demand for the drug over the forecast period which is responsible for excessive use of medical marijuana and also significantly contributes to the market for meditation for the treatment of a health condition. As a result, the government is focusing on raising awareness about the illnesses and the effect which significantly contributes to the market for medical marijuana. Therefore, the market for medical marijuana is expected to witness significant growth during the forecast period

Canopy Growth Corporation, Cannabis Sativa, Inc, GW Pharmaceuticals plc., Emerald Health Therapeutics Inc., Tilray, Aphria Inc, Aurora Cannabis, Cara Therapeutics, Medical Marijuana, and Pfizer Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst Application, chronic pain category accounted for the majority share in the market in 2020"

Based on application, the market is classified into chronic pain, arthritis, migraine, cancer, and others. The chronic pain category accounted for a significant share of the market. This is mainly due to the use of medical marijuana in the treatment of the increasing prevalence of pain, cancer, arthritis, and treatment of seizures in the global markets. For instance, in 2018, the Centers for Disease Control and Prevention (CDC) reported that an estimated 50 million Americans, or just over 20 percent, have some form of chronic pain. Over the forthcoming years, the rising application in the therapeutic field is likely to boost the demand for medical marijuana.

"Amongst Type, Oil and Tinctures are expected to witness highest CAGR during the forecast period"

Based on product, the market is categorized into flowers, oil and tinctures, edibles, and others. Among these, Oil and Tinctures are expected to witness the highest CAGR during the forecast period. This is mainly due to the strong prevalence of medical ability in the treatment of various health conditions and governments of many countries are either legalizing or approving it for medicinal use. Marijuana oils are preferred as they are a blend of cannabis extracts and inert carrier oils. The oils are easier to find and are expected to support the growth of the segment over the forecast period. These results boost the production of medical marijuana the continuous development of the new products and treatments is likely to strengthen the market of the segment during the forecast period

"North America to witness significant growth during the forecast period"

North America is expected to show the highest CAGR growth in the medical marijuana market. The major contributors to the growth of this market are US and Canada. This is mainly due to the growing various medical marijuana and therapeutic uses of marijuana products as well as the potential impact of marijuana legalization on the U.S. economy. For instance, in February 2020, Verda Innovations, a medical cannabis-based company in the U.S. announced the launch of its legal cannabis e-commerce and delivery platform in Canada, and U.S. Launch of such online platforms is considered to be one of the major factors expanding growth. Thus, increase in the number of countries legalizing it and an increase in the number of prescriptions filled for medicinal marijuana biopharmaceutical companies and diagnostics industry owing to the presence of well-established market players and frequent product launches in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global medical marijuana market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Medical Marijuana Market
• 2.2. Research Methodology of the Medical Marijuana Market
• 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL MEDICAL MARIJUANA MARKET COVID-19 IMPACT

6 GLOBAL MEDICAL MARIJUANA MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY APPLICATION

• 7.1. Chronic Pain
• 7.2. Arthritis
• 7.3. Migraine
• 7.4. Cancer
• 7.5. Others

8 MARKET INSIGHTS BY TYPE

• 8.1. Flowers
• 8.2. Oil and Tinctures
• 8.3. Edibles
• 8.4. Others

9 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

• 9.1. Dispensaries
• 9.2. Online Channel
• 9.3. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. UK
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Australia
  • 10.3.5. Rest of Asia-Pacific
• 10.4. Rest of World

11 MEDICAL MARIJUANA MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 MEDICAL MARIJUANA MARKET OPPORTUNITIES

13 MEDICAL MARIJUANA MARKET TRENDS

14 POLICY & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY-SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

• 18.1. Canopy Growth Corporation
• 18.2. CANNABIS SATIVA, INC
• 18.3. GW Pharmaceuticals plc.
• 18.4. Emerald Health Therapeutics Inc.
• 18.5. Tilray.
• 18.6. Aphria Inc
• 18.7. Aurora Cannabis
• 18.8. CARA THERAPEUTICS, INC
• 18.9. Medical Marijuana, Inc
• 18.10. Pfizer Inc.

19 DISCLAIMER